A new study confirmed the validity of a blood test that can diagnose patients with GLUT1 deficiency syndrome, a treatable neurometabolic disease that causes a wide range of neurologic symptoms in ...
None — 12-year-old Remi Savioz was diagnosed with a rare neuro-metabolic brain disease called Glucose Transporter 1, which affects the amount of glucose that reaches the brain. She is one of only 200 ...
Novato, CA, Oct. 27, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, ...
University of Texas at Arlington. "Challenging the current approach to Glut1 deficiency." ScienceDaily. ScienceDaily, 24 April 2017. <www.sciencedaily.com / releases / 2017 / 04 / 170424141230.htm>.
METAglut1TM obtains universal national coverage by French National Health Insurance as of February 22, 2024 Nationwide, patients with suspected Glut1 deficiency syndrome will benefit from ...
A deficiency in the protein responsible for moving glucose across the brain's protective blood-brain barrier appears to intensify the neurodegenerative effects of Alzheimer's disease, according to a ...
TWIST1 is a major regulator of epithelial mesenchymal transition process, essential in cancer metastasis. Cancer cells increase glucose uptake capabilities to meet their high energy requirements. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback